* BriaCell Therapeutics (NASDAQ:BCTX [https://seekingalpha.com/symbol/BCTX]) will consolidate its common shares on a 1-for-10 basis to meet Nasdaq listing requirements.
* The reverse split is expected to become effective on August 25, 2025.
* Post-Consolidation shares will begin trading on or about August 25, 2025.
* Source: Press release [https://seekingalpha.com/pr/20208433-briacell-announces-proposed-effective-date-of-share-consolidation]
MORE ON BRIACELL THERAPEUTICS CORP.
* Historical earnings data for BriaCell Therapeutics Corp. [https://seekingalpha.com/symbol/BCT:CA/earnings]
* Financial information for BriaCell Therapeutics Corp. [https://seekingalpha.com/symbol/BCT:CA/income-statement]
BriaCell to implement 1-for-10 reverse stock split to maintain Nasdaq listing
Published 2 months ago
Aug 21, 2025 at 4:39 PM
Neutral
Auto